Phytopharm
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Phytopharm - overview
Established
1995
Location
-, -, UK
Primary Industry
Pharmaceuticals
About
Based in the UK and founded in 1995, Phytopharm plc operates as a pharmaceutical company that researches and develops drugs and therapeutics for treating Parkinson's disease and other related conditions. The company developed several experimental drugs, including Cogane and Myogane, aimed at treating Parkinson’s disease. Phytopharm's portfolio includes treatments in various areas such as Hoodia gordonii, an appetite suppressant, and Phytopica, a product for canine skin health. The firm’s approach allows it to continue its mission while exploring opportunities for long-term growth in the pharmaceutical sector.
Primary Industry
Pharmaceuticals
Sub Industries
Specialty Pharmaceuticals, Pharmaceutical Research & Development
Website
www.phytopharm.com
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.